로그인
회원가입
Korean
Korean
English
Chinese
Japanese
Home
Introduction
Contact us
People
PI
Members
Research
Projects
Lab Facility
Publications
Papers
Books
Patents
Photo gallery
Photo gallery
Board
Projet update
Recruiting
Journal club
Home
People
Research
Publications
Photo gallery
Board
Home
Introduction
Contact us
People
PI
Members
Research
Projects
Lab Facility
Publications
Papers
Books
Patents
Photo gallery
Photo gallery
Board
Projet update
Recruiting
Journal club
MOON LAB SNS 바로가기
트위터
페이스북
네이버블로그
MOON LAB
홈페이지 바로가기
MOON LAB
Moon lab pursues development of novel therapeutics for breast, ovary, and prostate cancer
Journal club
전체(63)
Journal Club
Projet update
전체(63)
Journal Club
Projet update
번호
제목
이름
날짜
조회
48
ID3 promotes homologous recombination via non-transcriptional and transcriptional mechanisms and its…
Mithun Ghosh
121
2023.12.21
Mithun Ghosh
2023.12.21
121
47
Gene therapy drug: Zolgensma
강민실
114
2023.12.23
강민실
2023.12.23
114
46
S6K1 amplification confers innate resistance to CDK4/6 inhibitors through activating c-Myc pathway i…
Nar Bahadur Kat…
682
2022.09.22
Nar Bahadur Kat…
2022.09.22
682
45
Combination of eribulin plus AKT inhibitor evokes synergistic cytotoxicity in soft tissue sarcoma ce…
정영규
810
2022.08.02
정영규
2022.08.02
810
44
PI3K activation promotes resistance to eribulin in HER2-negative breast cancer
정영규
827
2022.05.30
정영규
2022.05.30
827
43
Role of Akt Activation in PARP Inhibitor Resistance in Cancer
강민실
860
2022.05.23
강민실
2022.05.23
860
42
Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethali…
Mithun Ghosh
827
2022.05.16
Mithun Ghosh
2022.05.16
827
41
Resistance to checkpoint blockade therapy through inactivation of antigen presentation
홍사덕
857
2022.05.09
홍사덕
2022.05.09
857
40
Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endo…
Nar Bahadur Kat…
901
2022.05.09
Nar Bahadur Kat…
2022.05.09
901
39
Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Im…
홍사덕
844
2022.05.09
홍사덕
2022.05.09
844
38
PI3K‑targeting strategy using alpelisib to enhance the antitumor effect of paclitaxel in human gastr…
정영규
1036
2022.03.28
정영규
2022.03.28
1036
37
1
BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombi…
1
Mithun Ghosh
1754
2022.03.14
Mithun Ghosh
2022.03.14
1754
36
Oncogenic PAX6 elicits CDK4/6 inhibitor resistance by epigenetically inactivating the LATS2‐Hippo si…
Nar Bahadur Kat…
1191
2022.03.07
Nar Bahadur Kat…
2022.03.07
1191
35
Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethali…
강민실
1288
2022.01.05
강민실
2022.01.05
1288
34
Understanding and overcoming resistance to PARP inhibitors in cancer therapy
홍사덕
1345
2021.12.14
홍사덕
2021.12.14
1345
초기화
날짜순
조회순
정렬
검색
1
2
3
4
5
Search
검색대상
제목
내용
제목+내용
회원아이디
회원아이디(코)
글쓴이
글쓴이(코)
또는
그리고
검색어
필수
검색
닫기
전화걸기
문자상담
PL
MEMBERS